Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells

4 Aug 2009

Abstract excerpt

Human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) provide remarkable cellular platforms to better understand human hematopoiesis and to develop clinically applicable hematopoietic cell-based therapies. Over the past decade, hESCs have been used to characterize molecular and cellular mechanisms underpinning the differentiation of hematopoietic progenitors and mature, functional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to CRISPR and Genetic Engineering
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19652198
DOI: 10.1182/blood-2009-03-191304

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cellsPMID 19652198Read ↗

Generation of Red Blood Cells from Human Pluripotent Stem Cells—An UpdateSemantic proximity Read ↗

Progress and obstacles towards generating hematopoietic stem cells from pluripotent stem cellsSemantic proximity Read ↗

Red blood cells from induced pluripotent stem cells: hurdles and developmentsSemantic proximity Read ↗

Advantages and challenges of ex vivo generation and expansion of human hematopoietic stem cells from pluripotent stem cellsSemantic proximity Read ↗

Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cellsSemantic proximity Read ↗

Blood Derived Induced Pluripotent Stem Cells (iPSCs): Benefits, Challenges and the Road AheadSemantic proximity Read ↗

Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicineSemantic proximity Read ↗

Current Applications of Human Pluripotent Stem Cells: Possibilities and ChallengesSemantic proximity Read ↗

Modeling blood diseases with human induced pluripotent stem cellsSemantic proximity Read ↗

Hematopoietic stem cell engineering at a crossroadsSemantic proximity Read ↗

The safety of human pluripotent stem cells in clinical treatmentSemantic proximity Read ↗

Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.